Charles Schwab
MDXG icon

Charles Schwab’s MiMedx Group MDXG Stock Holding History

Charles Schwab’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.78M Sell
1,241,916
-137,249
-10% -$501K ﹤0.01% 2505
2026
Q1 		$5.45M Buy
1,379,165
+159,576
+13% +$804K ﹤0.01% 2371
2025
Q4 		$8.26M Buy
1,219,589
+188,177
+18% +$1.32M ﹤0.01% 2228
2025
Q3 		$7.2M Sell
1,031,412
-60,786
-6% -$423K ﹤0.01% 2276
2025
Q2 		$6.67M Sell
1,092,198
-61,399
-5% -$408K ﹤0.01% 2204
2025
Q1 		$8.77M Sell
1,153,597
-243,914
-17% -$2.04M ﹤0.01% 2013
2024
Q4 		$13.4M Sell
1,397,511
-37,886
-3% -$295K ﹤0.01% 1882
2024
Q3 		$8.48M Buy
1,435,397
+92,726
+7% +$614K ﹤0.01% 2111
2024
Q2 		$9.3M Buy
1,342,671
+171,258
+15% +$1.2M ﹤0.01% 2077
2024
Q1 		$9.02M Buy
1,171,413
+37,200
+3% +$299K ﹤0.01% 2034
2023
Q4 		$9.95M Buy
1,134,213
+57,704
+5% +$423K ﹤0.01% 1990
2023
Q3 		$7.85M Buy
1,076,509
+85,792
+9% +$639K ﹤0.01% 2042
2023
Q2 		$6.55M Buy
990,717
+57,265
+6% +$292K ﹤0.01% 2114
2023
Q1 		$3.18M Buy
933,452
+1,602
+0.2% +$6.21K ﹤0.01% 2389
2022
Q4 		$2.59M Buy
931,850
+12,856
+1% +$38.4K ﹤0.01% 2487
2022
Q3 		$2.64M Buy
918,994
+183,487
+25% +$652K ﹤0.01% 2500
2022
Q2 		$2.55M Sell
735,507
-13,119
-2% -$51.4K ﹤0.01% 2487
2022
Q1 		$3.53M Buy
748,626
+16,348
+2% +$80K ﹤0.01% 2447
2021
Q4 		$4.42M Buy
732,278
+13,061
+2% +$90.7K ﹤0.01% 2406
2021
Q3 		$4.36M Buy
719,217
+15,011
+2% +$169K ﹤0.01% 2439
2021
Q2 		$8.81M Buy
704,206
+248,268
+54% +$2.69M ﹤0.01% 2063
2021
Q1 		$4.7M Buy
455,938
+13,994
+3% +$135K ﹤0.01% 2333
2020
Q4 		$4.01M Buy
+441,944
New +$3.18M ﹤0.01% 2329
2018
Q4 		– Sell
-628,093
Closed -$3.88M – 3151
2018
Q3 		$3.88M Sell
628,093
-33,441
-5% -$151K ﹤0.01% 2183
2018
Q2 		$4.23M Buy
661,534
+52,366
+9% +$373K ﹤0.01% 2088
2018
Q1 		$4.25M Sell
609,168
-7,974
-1% -$92.8K ﹤0.01% 2025
2017
Q4 		$7.78M Sell
617,142
-14,016
-2% -$171K 0.01% 1651
2017
Q3 		$7.5M Buy
631,158
+174,726
+38% +$2.59M 0.01% 1649
2017
Q2 		$6.83M Buy
456,432
+37,117
+9% +$495K 0.01% 1619
2017
Q1 		$4M Buy
419,315
+23,037
+6% +$195K ﹤0.01% 1890
2016
Q4 		$3.51M Buy
396,278
+21,022
+6% +$189K ﹤0.01% 1927
2016
Q3 		$3.22M Buy
375,256
+17,778
+5% +$141K ﹤0.01% 1898
2016
Q2 		$2.85M Buy
357,478
+7,680
+2% +$59.8K ﹤0.01% 1902
2016
Q1 		$3.06M Buy
349,798
+6,401
+2% +$53.2K ﹤0.01% 1819
2015
Q4 		$3.22M Sell
343,397
-353,013
-51% -$3.06M ﹤0.01% 1805
2015
Q3 		$6.72M Buy
696,410
+18,552
+3% +$196K 0.01% 1273
2015
Q2 		$7.86M Buy
677,858
+127,701
+23% +$1.31M 0.01% 1220
2015
Q1 		$5.72M Buy
550,157
+193,067
+54% +$1.81M 0.01% 1412
2014
Q4 		$4.12M Buy
357,090
+110,254
+45% +$1.09M 0.01% 1577
2014
Q3 		$1.76M Buy
246,836
+32,060
+15% +$223K ﹤0.01% 2038
2014
Q2 		$1.52M Sell
214,776
-848
-0.4% -$4.96K ﹤0.01% 2123
2014
Q1 		$1.32M Buy
215,624
+17,460
+9% +$128K ﹤0.01% 2153
2013
Q4 		$1.73M Buy
198,164
+33,621
+20% +$206K ﹤0.01% 2001
2013
Q3 		$792K Sell
164,543
-1,749
-1% -$9.64K ﹤0.01% 2333
2013
Q2 		$1.17M Buy
+166,292
New +$1.16M ﹤0.01% 2067

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Charles Schwab's MDXG Position: Q2 2026 in Review

Charles Schwab reduced its MiMedx Group (MDXG) stake by 10% in Q2 2026, selling an estimated $501K and leaving 1,241,916 shares worth $4.78M. The position accounts for ﹤0.01% of the portfolio, ranked #2505.

Charles Schwab first reported a position in MDXG in Q2 2013 and has held it in 45 quarters since. The position peaked at $13.4M in Q4 2024. 226 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • Charles Schwab held 1,241,916 shares of MiMedx Group worth $4.78M as of Q2 2026.
  • Charles Schwab sold 137,249 MiMedx Group shares in Q2 2026, an estimated $501K.
  • MiMedx Group made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2505 holding.
  • Charles Schwab first reported a position in MiMedx Group in Q2 2013 and has held it in 45 quarters since.
  • Charles Schwab's MiMedx Group position peaked at $13.4M in Q4 2024.
  • 226 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.